You are here: Industry Insights > I-Mab

News List

I-Mab gets USFDA IND approval for its proprietary TJC4 biospectrumasia
January 30, 2019
I-Mab Biopharma (I-Mab) announced recently that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs pharmafocusasia
December 03, 2018
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer......
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine prnasia
December 26, 2017
Genexine to receive an upfront payment and entitled to tiered, single-digit royalties on net sales of HyLeukin plus milestone payments from I-Mab Biopharma (I-Mab).
I-Mab signs $120 M deal with MorphoSys biospectrumasia
December 06, 2017
MorphoSys will be receiving $120 million in upfront and milestone payments.

Previous page 1 2 3 4 5 6 Next page